- Home
- AGEN vs BZFD Comparison
AGEN vs BZFD Comparison
Compare AGEN & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- BZFD
- Stock Information
- Founded
- AGEN 1994
- BZFD 2006
- Country
- AGEN United States
- BZFD United States
- Employees
- AGEN N/A
- BZFD N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- BZFD Movies/Entertainment
- Sector
- AGEN Health Care
- BZFD Consumer Discretionary
- Exchange
- AGEN Nasdaq
- BZFD Nasdaq
- Market Cap
- AGEN 96.2M
- BZFD 111.0M
- IPO Year
- AGEN 2000
- BZFD N/A
- Fundamental
- Price
- AGEN $3.83
- BZFD $2.74
- Analyst Decision
- AGEN Buy
- BZFD
- Analyst Count
- AGEN 3
- BZFD 0
- Target Price
- AGEN $10.50
- BZFD N/A
- AVG Volume (30 Days)
- AGEN 399.9K
- BZFD 558.5K
- Earning Date
- AGEN 03-13-2025
- BZFD 03-13-2025
- Dividend Yield
- AGEN N/A
- BZFD N/A
- EPS Growth
- AGEN N/A
- BZFD N/A
- EPS
- AGEN N/A
- BZFD N/A
- Revenue
- AGEN $160,427,000.00
- BZFD $231,670,000.00
- Revenue This Year
- AGEN N/A
- BZFD $35.96
- Revenue Next Year
- AGEN $36.13
- BZFD $4.81
- P/E Ratio
- AGEN N/A
- BZFD N/A
- Revenue Growth
- AGEN 59.00
- BZFD 6.51
- 52 Week Low
- AGEN $2.50
- BZFD $0.64
- 52 Week High
- AGEN $19.69
- BZFD $5.68
- Technical
- Relative Strength Index (RSI)
- AGEN 65.58
- BZFD 42.19
- Support Level
- AGEN $3.08
- BZFD $2.55
- Resistance Level
- AGEN $3.29
- BZFD $3.12
- Average True Range (ATR)
- AGEN 0.27
- BZFD 0.19
- MACD
- AGEN 0.08
- BZFD 0.03
- Stochastic Oscillator
- AGEN 94.84
- BZFD 33.33
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.